Press Releases

All Releases
View Summary Ironwood Pharmaceuticals to Highlight Clinical Data for IW-3718 in Persistent Gastroesophageal Reflux Disease (GERD) at Digestive Disease Week® 2018
May 23, 2018
PDF 20.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Sends Letter to Shareholders Highlighting Director Nominees
May 14, 2018
PDF 37.3 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Investor Presentation Highlighting Actions Taken Designed to Unlock Shareholder Value
May 9, 2018
PDF 21.1 KB Add to Briefcase
View Summary Ironwood and Allergan Announce Settlement with Aurobindo Pharma Resolving LINZESS® (linaclotide) Patent Litigation
May 3, 2018
PDF 284.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Files Definitive Proxy Materials and Mails Letter to Shareholders
May 2, 2018
PDF 112.2 KB Add to Briefcase
View Summary Allergan and Ironwood Launch Interactive Digital Destination During Irritable Bowel Syndrome (IBS) Awareness Month Designed to Encourage Sufferers to Get Educated and Take Action
May 1, 2018
PDF 299.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Intent to Separate Soluble Guanylate Cyclase (sGC) Business from Commercial and Gastrointestinal Business
May 1, 2018
PDF 85.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides First Quarter 2018 Investor Update
May 1, 2018
PDF 97.7 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host First Quarter 2018 Investor Update Call
Apr 17, 2018
PDF 11.0 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Announces Director Nomination from Sarissa Capital
Apr 9, 2018
PDF 16.1 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Upcoming March Investor Conferences
Mar 5, 2018
PDF 279.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2017 Investor Update
Feb 15, 2018
PDF 109.9 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Investor Update Call
Feb 1, 2018
PDF 277.7 KB Add to Briefcase
View Summary Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS® (linaclotide) Patent Litigation
Jan 16, 2018
PDF 284.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 2, 2018
PDF 277.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Initiates Phase II Clinical Trial of sGC Stimulator IW-1701 in Patients with Sickle Cell Disease
Dec 21, 2017
PDF 323.2 KB Add to Briefcase
View Summary Ironwood Reports Top-line Phase IIa Data for IW-1973 Demonstrating Positive Cardiovascular, Metabolic and Endothelial Effects
Dec 4, 2017
PDF 554.4 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Strengthens Executive Leadership Team
Nov 28, 2017
PDF 548.6 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals Provides Third Quarter 2017 Investor Update
Nov 2, 2017
PDF 372.5 KB Add to Briefcase
View Summary Ironwood Pharmaceuticals to Present at Credit Suisse 26th Annual Healthcare Conference
Nov 1, 2017
PDF 278.9 KB Add to Briefcase
Showing 1-20 of 266 Page: 1 2 3 4 5 ... 14  Next 20
Add to Briefcase = add release to Briefcase
You are now leaving ironwoodpharma.com. This link will take you to
a website to which our privacy policy does not apply. You are solely
responsible for your interactions with that website.